Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Apollo Medical Holdings

Nasdaq:AMEH
Snowflake Description

Proven track record with mediocre balance sheet.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AMEH
Nasdaq
$438M
Market Cap
  1. Home
  2. US
  3. Healthcare
Company description

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The last earnings update was 18 days ago. More info.


Add to Portfolio Compare Print
  • Apollo Medical Holdings has significant price volatility in the past 3 months.
AMEH Share Price and Events
7 Day Returns
-5.3%
NasdaqCM:AMEH
1.9%
US Healthcare
-1.1%
US Market
1 Year Returns
-36.6%
NasdaqCM:AMEH
-1.7%
US Healthcare
-13.6%
US Market
AMEH Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Apollo Medical Holdings (AMEH) -5.3% -26.1% -31% -36.6% - -
US Healthcare 1.9% -10.3% -16.7% -1.7% 14.9% 15.7%
US Market -1.1% -17.8% -22.5% -13.6% 4.9% 16.3%
1 Year Return vs Industry and Market
  • AMEH underperformed the Healthcare industry which returned -1.7% over the past year.
  • AMEH underperformed the Market in United States of America which returned -13.6% over the past year.
Price Volatility
AMEH
Industry
5yr Volatility vs Market

Value

 Is Apollo Medical Holdings undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Apollo Medical Holdings to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Apollo Medical Holdings.

NasdaqCM:AMEH Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 1 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 7%
Perpetual Growth Rate 10-Year US Government Bond Rate 1.7%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for NasdaqCM:AMEH
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year US Govt Bond Rate 1.7%
Equity Risk Premium S&P Global 5.4%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.66
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.656 (1 + (1- 21%) (58.54%))
0.973
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.97
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 1.74% + (0.973 * 5.44%)
7.03%

Discounted Cash Flow Calculation for NasdaqCM:AMEH using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Apollo Medical Holdings is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

NasdaqCM:AMEH DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 7.03%)
2020 6.92 Est @ -42.31% 6.47
2021 4.91 Est @ -29.1% 4.28
2022 3.93 Est @ -19.84% 3.21
2023 3.41 Est @ -13.37% 2.60
2024 3.11 Est @ -8.84% 2.21
2025 2.93 Est @ -5.66% 1.95
2026 2.83 Est @ -3.44% 1.76
2027 2.78 Est @ -1.89% 1.61
2028 2.75 Est @ -0.8% 1.49
2029 2.75 Est @ -0.04% 1.40
Present value of next 10 years cash flows $26.00
NasdaqCM:AMEH DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $2.75 × (1 + 1.74%) ÷ (7.03% – 1.74%)
$52.93
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $52.93 ÷ (1 + 7.03%)10
$26.83
NasdaqCM:AMEH Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $26.00 + $26.83
$52.83
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $52.83 / 35.35
$1.49
NasdaqCM:AMEH Discount to Share Price
Calculation Result
Value per share (USD) From above. $1.49
Current discount Discount to share price of $12.40
= -1 x ($12.40 - $1.49) / $1.49
-729.6%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Apollo Medical Holdings is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Apollo Medical Holdings's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Apollo Medical Holdings's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
NasdaqCM:AMEH PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.41
NasdaqCM:AMEH Share Price ** NasdaqCM (2020-04-02) in USD $12.4
United States of America Healthcare Industry PE Ratio Median Figure of 45 Publicly-Listed Healthcare Companies 20.62x
United States of America Market PE Ratio Median Figure of 2,943 Publicly-Listed Companies 12.9x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Apollo Medical Holdings.

NasdaqCM:AMEH PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqCM:AMEH Share Price ÷ EPS (both in USD)

= 12.4 ÷ 0.41

30.49x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Apollo Medical Holdings is overvalued based on earnings compared to the US Healthcare industry average.
  • Apollo Medical Holdings is overvalued based on earnings compared to the United States of America market.
Price based on expected Growth
Does Apollo Medical Holdings's expected growth come at a high price?
Raw Data
NasdaqCM:AMEH PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 30.49x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 1 Analysts
Not available
United States of America Healthcare Industry PEG Ratio Median Figure of 32 Publicly-Listed Healthcare Companies 1.59x
United States of America Market PEG Ratio Median Figure of 2,006 Publicly-Listed Companies 0.95x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Apollo Medical Holdings, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Apollo Medical Holdings's assets?
Raw Data
NasdaqCM:AMEH PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $5.33
NasdaqCM:AMEH Share Price * NasdaqCM (2020-04-02) in USD $12.4
United States of America Healthcare Industry PB Ratio Median Figure of 95 Publicly-Listed Healthcare Companies 2.29x
United States of America Market PB Ratio Median Figure of 5,140 Publicly-Listed Companies 1.25x
NasdaqCM:AMEH PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqCM:AMEH Share Price ÷ Book Value per Share (both in USD)

= 12.4 ÷ 5.33

2.32x

* Primary Listing of Apollo Medical Holdings.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Apollo Medical Holdings is overvalued based on assets compared to the US Healthcare industry average.
X
Value checks
We assess Apollo Medical Holdings's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Apollo Medical Holdings has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Apollo Medical Holdings expected to perform in the next 1 to 3 years based on estimates from 1 analyst?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
13.6%
Expected Healthcare industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Apollo Medical Holdings expected to grow at an attractive rate?
  • Unable to compare Apollo Medical Holdings's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Apollo Medical Holdings's earnings growth to the United States of America market average as no estimate data is available.
  • Unable to compare Apollo Medical Holdings's revenue growth to the United States of America market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
NasdaqCM:AMEH Future Growth Rates Data Sources
Data Point Source Value (per year)
United States of America Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 13.6%
United States of America Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 6.6%
United States of America Market Earnings Growth Rate Market Cap Weighted Average 12.3%
United States of America Market Revenue Growth Rate Market Cap Weighted Average 7.2%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
NasdaqCM:AMEH Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
NasdaqCM:AMEH Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2020-12-31 675 30 1
2020-04-03
NasdaqCM:AMEH Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 561 14 14
2019-09-30 488 4 4
2019-06-30 499 -10 10
2019-03-31 492 17 9
2018-12-31 520 25 11
2018-09-30 506 47 28
2018-06-30 436 41 24
2018-03-31 395 35 24
2017-12-31 356 52 26
2017-09-30 336 44 13
2017-06-30 323 45 11
2017-03-31 317 47 12

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Apollo Medical Holdings is high growth as no earnings estimate data is available.
  • Unable to determine if Apollo Medical Holdings is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
NasdaqCM:AMEH Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below

All data from Apollo Medical Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:AMEH Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2020-12-31 0.75 0.75 0.75 1.00
2020-04-03
NasdaqCM:AMEH Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.41
2019-09-30 0.13
2019-06-30 0.29
2019-03-31 0.26
2018-12-31 0.33
2018-09-30 0.89
2018-06-30 0.83
2018-03-31 0.86
2017-12-31 1.01
2017-09-30 0.04
2017-06-30 0.03
2017-03-31 0.03

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Apollo Medical Holdings will efficiently use shareholders’ funds in the future without estimates of Return on Equity.
X
Future performance checks
We assess Apollo Medical Holdings's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the United States of America market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the United States of America market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Apollo Medical Holdings has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Apollo Medical Holdings performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Apollo Medical Holdings's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Apollo Medical Holdings's year on year earnings growth rate has been positive over the past 5 years.
  • Apollo Medical Holdings's 1-year earnings growth exceeds its 5-year average (30.3% vs 9.5%)
  • Apollo Medical Holdings's earnings growth has exceeded the US Healthcare industry average in the past year (30.3% vs 14%).
Earnings and Revenue History
Apollo Medical Holdings's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Apollo Medical Holdings Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

NasdaqCM:AMEH Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 560.62 14.12 40.12
2019-09-30 488.46 4.29 43.63
2019-06-30 499.12 9.70 44.72
2019-03-31 491.74 8.81 46.11
2018-12-31 519.91 10.84 46.44
2018-09-30 505.89 27.77 42.30
2018-06-30 436.30 24.28 37.64
2018-03-31 394.94 23.61 32.59
2017-12-31 356.36 25.80 26.25
2017-09-30 335.61 13.32 22.18
2017-06-30 323.46 11.50 23.11
2017-03-31 316.85 11.98 22.09
2016-12-31 305.93 11.45 21.03
2015-12-31 313.12 12.82 26.78
2014-12-31 134.34 -0.63 35.56

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Apollo Medical Holdings has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Apollo Medical Holdings used its assets less efficiently than the US Healthcare industry average last year based on Return on Assets.
  • Apollo Medical Holdings has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Apollo Medical Holdings's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Apollo Medical Holdings has a total score of 4/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Apollo Medical Holdings's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Apollo Medical Holdings's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Apollo Medical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Apollo Medical Holdings's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Apollo Medical Holdings's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is covered by short term assets, assets are 1.4x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Apollo Medical Holdings Company Filings, last reported 3 months ago.

NasdaqCM:AMEH Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 361.06 241.67 219.73
2019-09-30 368.40 243.65 231.45
2019-06-30 405.67 44.60 53.88
2019-03-31 394.81 13.00 94.15
2018-12-31 406.66 13.04 108.02
2018-09-30 410.27 13.16 124.36
2018-06-30 370.73 13.28 103.56
2018-03-31 361.14 5.39 106.26
2017-12-31 336.31 5.54 100.89
2017-09-30 178.49 0.00 78.43
2017-06-30 166.47 0.00 67.89
2017-03-31 165.61 0.00 65.32
2016-12-31 250.44 0.00 56.93
2015-12-31 169.21 2.08 62.42
2014-12-31 101.55 1.53 32.14
  • Apollo Medical Holdings's level of debt (66.9%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (1.5% vs 66.9% today).
  • Debt is not well covered by operating cash flow (5.7%, less than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 12.7x coverage).
X
Financial health checks
We assess Apollo Medical Holdings's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Apollo Medical Holdings has a total score of 3/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Apollo Medical Holdings's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Apollo Medical Holdings dividends.
If you bought $2,000 of Apollo Medical Holdings shares you are expected to receive $0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Apollo Medical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Apollo Medical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
NasdaqCM:AMEH Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 1 Analyst Estimates (S&P Global) See Below
United States of America Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 20 Stocks 1.8%
United States of America Market Average Dividend Yield Market Cap Weighted Average of 1943 Stocks 3.1%
United States of America Minimum Threshold Dividend Yield 10th Percentile 1.1%
United States of America Bottom 25% Dividend Yield 25th Percentile 2%
United States of America Top 25% Dividend Yield 75th Percentile 5.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

NasdaqCM:AMEH Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2020-12-31
2020-04-03

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Apollo Medical Holdings has not reported any payouts.
  • Unable to verify if Apollo Medical Holdings's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Apollo Medical Holdings's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Apollo Medical Holdings has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Apollo Medical Holdings's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.1%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Apollo Medical Holdings afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Apollo Medical Holdings has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Apollo Medical Holdings's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Kenneth Sim
TENURE AS CEO 0.6 years
CEO Bio

Dr. Kenneth T. Sim, M.D., serves as Co-Chief Executive Officer at Apollo Medical Holdings, Inc. since September 30, 2019. Dr. Simhas been an Executive Chairman of Apollo Medical Holdings, Inc. since December 08, 2017. Dr. Sim was the Chairman of NMM since 2013 and its Director since 2006. Dr. Sim serves as the Chairman of APC. Dr. Sim is also a member of the Governing Board of Directors at Alhambra Hospital Medical Center and a Board Member on the National Council of Asian Pacific Islander Physicians. As an entrepreneur, Dr. Sim founded “Healthcare City” in the City of Industry, California, which helped streamline the healthcare process by providing outpatient health services at one location including surgical center, senior wellness center, laboratory, radiology and urgent care. Dr. Sim is a Fellow of the American College of Surgeons and was awarded the Independent Physician Leadership Award in 2014 by the Los Angeles County Medical Association. He received his Bachelor's degree from the University of California Los Angeles and received his medical training from the Loma Linda University School of Medicine and the Autonomous University of Guadalajara, Guadalajara, Mexico.

CEO Compensation
  • Insufficient data for Kenneth to compare compensation growth.
  • Insufficient data for Kenneth to establish whether their remuneration is reasonable compared to companies of similar size in United States of America.
Management Team Tenure

Average tenure of the Apollo Medical Holdings management team in years:

0.6
Average Tenure
  • The average tenure for the Apollo Medical Holdings management team is less than 2 years, this suggests a new team.
Management Team

Kenneth Sim

TITLE
Executive Chairman & Co-Chief Executive Officer
TENURE
0.6 yrs

Thomas Lam

TITLE
President
AGE
70
TENURE
0.6 yrs

Eric Chin

TITLE
CFO & Corporate Secretary
TENURE
1.8 yrs

Hing Ang

TITLE
Chief Operating Officer
TENURE
2.3 yrs

Brandon Sim

TITLE
Interim Chief Technology Officer
TENURE
0.6 yrs

Albert Young WaiChow

TITLE
Chief Administrative Officer
TENURE
0.6 yrs

Adrian Vazquez

TITLE
Chief Medical Officer
AGE
49
Board of Directors Tenure

Average tenure and age of the Apollo Medical Holdings board of directors in years:

2.3
Average Tenure
70.5
Average Age
  • The average tenure for the Apollo Medical Holdings board of directors is less than 3 years, this suggests a new board.
Board of Directors

Thomas Lam

TITLE
President
AGE
70
TENURE
2.3 yrs

Mark Fawcett

TITLE
Independent Director
AGE
52

Kenneth Sim

TITLE
Executive Chairman & Co-Chief Executive Officer
TENURE
2.3 yrs

Michael Eng

TITLE
Director
TENURE
2.3 yrs

Dave Schmidt

TITLE
Independent Director
AGE
71
TENURE
2.3 yrs

Mitchell Kitayama

TITLE
Independent Director
TENURE
2.3 yrs

Li Yu

TITLE
Director
TENURE
2.3 yrs

Ernest Bates

TITLE
Director
AGE
82
TENURE
1.8 yrs

Linda Marsh

TITLE
Director
TENURE
1.3 yrs

John Chiang

TITLE
Independent Director
TENURE
1.3 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price ($) Value ($)
18. Dec 19 Buy Allied Physicians of California IPA Company 18. Dec 19 18. Dec 19 15,000 $18.50 $277,500
17. Dec 19 Buy Allied Physicians of California IPA Company 17. Dec 19 17. Dec 19 15,000 $18.47 $277,050
16. Dec 19 Buy Allied Physicians of California IPA Company 16. Dec 19 16. Dec 19 15,000 $18.94 $284,100
12. Dec 19 Buy Allied Physicians of California IPA Company 12. Dec 19 12. Dec 19 23,673 $18.06 $427,534
13. Dec 19 Buy Allied Physicians of California IPA Company 11. Dec 19 13. Dec 19 63,255 $18.32 $1,135,701
10. Dec 19 Buy Allied Physicians of California IPA Company 10. Dec 19 10. Dec 19 23,462 $16.75 $392,989
09. Dec 19 Buy Allied Physicians of California IPA Company 09. Dec 19 09. Dec 19 38,600 $17.60 $679,360
06. Dec 19 Buy Allied Physicians of California IPA Company 06. Dec 19 06. Dec 19 32,363 $18.95 $613,279
06. Dec 19 Buy Michael Eng Individual 04. Dec 19 04. Dec 19 1,890 $18.48 $34,927
05. Dec 19 Buy Allied Physicians of California IPA Company 05. Dec 19 05. Dec 19 13,595 $18.64 $253,411
04. Dec 19 Buy Allied Physicians of California IPA Company 04. Dec 19 04. Dec 19 18,539 $18.36 $340,376
03. Dec 19 Buy Allied Physicians of California IPA Company 03. Dec 19 03. Dec 19 20,000 $18.24 $364,800
02. Dec 19 Buy Allied Physicians of California IPA Company 29. Nov 19 02. Dec 19 25,102 $18.46 $453,710
27. Nov 19 Buy Allied Physicians of California IPA Company 26. Nov 19 27. Nov 19 12,500 $18.22 $225,150
25. Nov 19 Buy Allied Physicians of California IPA Company 25. Nov 19 25. Nov 19 33,000 $17.32 $571,560
22. Nov 19 Buy Allied Physicians of California IPA Company 22. Nov 19 22. Nov 19 25,000 $17.79 $444,750
20. Nov 19 Buy Allied Physicians of California IPA Company 20. Nov 19 20. Nov 19 12,100 $17.28 $209,088
21. Nov 19 Buy Allied Physicians of California IPA Company 19. Nov 19 21. Nov 19 20,103 $17.50 $327,593
18. Nov 19 Buy Kenneth Sim Individual 14. Nov 19 14. Nov 19 10,000 $14.67 $146,700
15. Nov 19 Buy Thomas Lam Individual 14. Nov 19 14. Nov 19 10,000 $14.84 $148,400
29. Oct 19 Buy Kenneth Sim Individual 08. Oct 19 08. Oct 19 5,000 $15.55 $77,750
17. Sep 19 Sell Adrian Vazquez Individual 11. Sep 19 13. Sep 19 -84,800 $20.14 $-1,697,753
17. Sep 19 Buy Michael Eng Individual 12. Sep 19 12. Sep 19 2,000 $20.28 $40,560
20. Aug 19 Buy Albert Young WaiChow Individual 14. Aug 19 14. Aug 19 5,000 $15.01 $75,050
20. Aug 19 Buy Thomas Lam Individual 14. Aug 19 15. Aug 19 17,200 $16.85 $280,740
20. Aug 19 Buy Michael Eng Individual 19. Aug 19 19. Aug 19 1,000 $15.97 $15,970
20. Aug 19 Buy Kenneth Sim Individual 14. Aug 19 16. Aug 19 6,000 $16.35 $96,060
19. Jun 19 Buy Lakhi Sakhrani Individual 11. Jun 19 12. Jun 19 7,521 $14.70 $110,496
18. Jun 19 Buy John Chiang Individual 14. Jun 19 14. Jun 19 100 $16.31 $1,631
14. Jun 19 Buy Eric Chin Individual 12. Jun 19 12. Jun 19 2,040 $14.72 $30,029
13. Jun 19 Buy Mark Fawcett Individual 11. Jun 19 11. Jun 19 10,000 $14.13 $141,300
13. Jun 19 Buy Thomas Lam Individual 11. Jun 19 11. Jun 19 6,900 $14.64 $101,016
13. Jun 19 Buy Kenneth Sim Individual 11. Jun 19 12. Jun 19 6,996 $14.51 $101,434
05. Jun 19 Sell Adrian Vazquez Individual 03. Jun 19 04. Jun 19 -85,000 $16.64 $-1,390,170
X
Management checks
We assess Apollo Medical Holdings's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Apollo Medical Holdings has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Should We Be Cautious About Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) ROE Of 11%?

View our latest analysis for Apollo Medical Holdings How Do I Calculate Return On Equity? … The formula for return on equity is: Return on Equity = Net Profit ÷ Shareholders' Equity Or for Apollo Medical Holdings: 11% = US$8.8m ÷ US$395m (Based on the trailing twelve months to March 2019.) It's easy to understand the 'net profit' part of that equation, but 'shareholders' equity' requires further explanation. … Does Apollo Medical Holdings Have A Good Return On Equity?

Simply Wall St -

The Apollo Medical Holdings (NASDAQ:AMEH) Share Price Is Down 44% So Some Shareholders Are Getting Worried

Because Apollo Medical Holdings hasn't been listed for many years, the market is still learning about how the business performs. … A Different Perspective While Apollo Medical Holdings shareholders are down 44% for the year, the market itself is up 5.6%. … Apollo Medical Holdings is not the only stock insiders are buying.

Simply Wall St -

Why Apollo Medical Holdings, Inc.’s (NASDAQ:AMEH) Return On Capital Employed Is Impressive

Analysts use this formula to calculate return on capital employed: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) Or for Apollo Medical Holdings: 0.15 = US$67m ÷ (US$521m - US$88m) (Based on the trailing twelve months to March 2019.) Therefore, Apollo Medical Holdings has an ROCE of 15%. … Apollo Medical Holdings's Current Liabilities And Their Impact On Its ROCE Short term (or current) liabilities, are things like supplier invoices, overdrafts, or tax bills that need to be paid within 12 months. … Due to the way ROCE is calculated, a high level of current liabilities makes a company look as though it has less capital employed, and thus can (sometimes unfairly) boost the ROCE.

Simply Wall St -

Could Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) Investor Composition Influence The Stock Price?

As Charlie Munger said 'Show me the incentive and I will show you the outcome.' With a market capitalization of US$538m, Apollo Medical Holdings is a small cap stock, so it might not be well known by many institutional investors. … See our latest analysis for Apollo Medical Holdings NasdaqCM:AMEH Ownership Summary, June 14th 2019 What Does The Institutional Ownership Tell Us About Apollo Medical Holdings? … We can see that Apollo Medical Holdings does have institutional investors; and they hold 6.8% of the stock.

Simply Wall St -

Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Insiders Have Been Selling

See our latest analysis for Apollo Medical Holdings The Last 12 Months Of Insider Transactions At Apollo Medical Holdings In the last twelve months, the biggest single sale by an insider was when the Co-Chief Medical Officer, Adrian Vazquez, sold US$3.9m worth of shares at a price of US$18.56 per share. … Does Apollo Medical Holdings Boast High Insider Ownership? … It's heartening that insiders own plenty of stock, but we'd like to see more insider buying, since the last year of Apollo Medical Holdings insider transactions don't fill us with confidence.

Simply Wall St -

What Does Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) P/E Ratio Tell You?

To keep it practical, we'll show how Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) P/E ratio could help you assess the value on offer. … Apollo Medical Holdings has a P/E ratio of 60.41, based on the last twelve months. … Price to Earnings Ratio = Price per Share ÷ Earnings per Share (EPS)

Simply Wall St -

Did You Miss Apollo Medical Holdings's (NASDAQ:AMEH) 30% Share Price Gain?

We'll need to follow Apollo Medical Holdings for a while to get a better sense of its share price trend, since it hasn't been listed for particularly long. … By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. … During the last year, Apollo Medical Holdings actually saw its earnings per share drop 67%.

Simply Wall St -

Is Apollo Medical Holdings, Inc.'s (NASDAQ:AMEH) ROE Of 15% Impressive?

Over the last twelve months Apollo Medical Holdings has recorded a ROE of 15%. … One way to conceptualize this, is that for each $1 of shareholders' equity it has, the company made $0.15 in profit. … Return on Equity = Net Profit ÷ Shareholders' Equity

Simply Wall St -

Should You Be Holding Apollo Medical Holdings, Inc. (NASDAQ:AMEH)?

Building up an investment case requires looking at a stock holistically. … Today I've chosen to put the spotlight on Apollo Medical Holdings, Inc. … In the following section, I expand a bit more on these key aspects

Simply Wall St -

How Much Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Do Insiders Own?

Every investor in Apollo Medical Holdings, Inc. … I generally like to see some degree of insider ownership, even if only a little. … With a market capitalization of US$645m, Apollo Medical Holdings is a small cap stock, so it might not be well known by many institutional investors.

Simply Wall St -

Company Info

Description

Apollo Medical Holdings, Inc., a physician-centric integrated population health management company, provides medical care services. The company offers care coordination services to principal constituents of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. Its physician network consists of primary care physicians, specialist physicians, and hospitalists. The company serves the patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organizations; and non-insured patients in California. Apollo Medical Holdings, Inc. was founded in 1994 and is headquartered in Alhambra, California.

Details
Name: Apollo Medical Holdings, Inc.
AMEH
Exchange: NasdaqCM
Founded: 1994
$438,282,674
35,345,377
Website: http://www.apollomed.net
Address: Apollo Medical Holdings, Inc.
1668 South Garfield Avenue,
2nd Floor,
Alhambra,
California, 91801,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqCM AMEH Common Stock Nasdaq Capital Market US USD 11. Dec 2017
Number of employees
Current staff
Staff numbers
551
Apollo Medical Holdings employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/03 01:09
End of day share price update: 2020/04/02 00:00
Last estimates confirmation: 2020/03/16
Last earnings filing: 2020/03/16
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.